{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:10:55Z","timestamp":1782821455117,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Applied Microbiology Research Center of Baqiyatallah University of Medical Sciences, Tehran-Iran","award":["97000558"],"award-info":[{"award-number":["97000558"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.micpath.2020.104700","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T18:35:04Z","timestamp":1608230104000},"page":"104700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates"],"prefix":"10.1016","volume":"150","author":[{"given":"Abolfazl","family":"Jahangiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Neshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali","family":"Mirhosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiarash","family":"Ghazvini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosna","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Sedighian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.micpath.2020.104700_bib1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"11","key":"10.1016\/j.micpath.2020.104700_bib2","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1093\/jac\/dky290","article-title":"Phylogenomics of colistin-susceptible and resistant XDR Acinetobacter baumannii","volume":"73","author":"Mustapha","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"issue":"12","key":"10.1016\/j.micpath.2020.104700_bib3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nrd3957-c1","article-title":"The value of single-pathogen antibacterial agents","volume":"12","author":"Spellberg","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.micpath.2020.104700_bib4","doi-asserted-by":"crossref","first-page":"104238","DOI":"10.1016\/j.micpath.2020.104238","article-title":"Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections","volume":"146","author":"Neshani","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2020.104700_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.meegid.2018.09.028","article-title":"Diversity of aminoglycoside modifying enzymes and 16S rRNA methylases in Acinetobacter baumannii and Acinetobacter nosocomialis species in Iran; wide distribution of aadA1 and armA. Infection, genetics and evolution","volume":"66","author":"Salimizand","year":"2018","journal-title":"J. Mol. Epidemiol. Evol. Genetics Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2020.104700_bib6","first-page":"62","article-title":"Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran","volume":"8","author":"Goli","year":"2016","journal-title":"Iran. J. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2020.104700_bib7","first-page":"38","article-title":"Molecular epidemiology of colistin-resistant Pseudomonas aeruginosa producing NDM-1 from hospitalized patients in Iran","volume":"22","author":"Sheikh","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2020.104700_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijmm.2015.11.004","article-title":"Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options","volume":"306","author":"Chatterjee","year":"2016","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2020.104700_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.trivac.2016.03.001","article-title":"Development of immunization trials against Acinetobacter baumannii","volume":"5","author":"Ahmad","year":"2016","journal-title":"Trials Vaccinol."},{"issue":"8","key":"10.1016\/j.micpath.2020.104700_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/sur.2018.233","article-title":"Progress toward the elusive Pseudomonas aeruginosa vaccine","volume":"19","author":"Merakou","year":"2018","journal-title":"Surg. Infect."},{"key":"10.1016\/j.micpath.2020.104700_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"Lee","year":"2017","journal-title":"Front. Cellular Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2020.104700_bib12","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s10989-020-10056-0","article-title":"Outer membrane protein, Oma87 prevents acinetobacter baumannii infection","volume":"26","author":"Rasooli","year":"2020","journal-title":"Int. J. Pept. Res. Therapeut."},{"issue":"7","key":"10.1016\/j.micpath.2020.104700_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/apm.13061","article-title":"Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein","volume":"128","author":"Mahmoudi","year":"2020","journal-title":"APMIS"},{"key":"10.1016\/j.micpath.2020.104700_bib14","doi-asserted-by":"crossref","first-page":"100708","DOI":"10.1016\/j.genrep.2020.100708","article-title":"Passive immunization with chitosan-loaded biofilm-associated protein against Acinetobacter baumannii murine infection model","author":"Eslam","year":"2020","journal-title":"Gene Rep."},{"issue":"2","key":"10.1016\/j.micpath.2020.104700_bib15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jam.14135","article-title":"Specific egg yolk antibodies (IgY) confer protection against Acinetobacter baumannii in a murine pneumonia model","volume":"126","author":"Jahangiri","year":"2019","journal-title":"J. Appl. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2020.104700_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10989-017-9665-6","article-title":"Antigenic properties of iron regulated proteins in Acinetobacter baumannii: an in silico approach","volume":"25","author":"Bazmara","year":"2019","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.micpath.2020.104700_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mimet.2017.11.008","article-title":"Highly conserved exposed immunogenic peptides of Omp34 against Acinetobacter baumannii: an innovative approach","volume":"144","author":"Jahangiri","year":"2018","journal-title":"J. Microbiol. Methods"},{"issue":"2","key":"10.1016\/j.micpath.2020.104700_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.30699\/ijp.2017.24875","article-title":"Conserved OprF as a selective immunogen against Pseudomonas aeruginosa","volume":"12","author":"Kazemi Moghaddam","year":"2017","journal-title":"Iran. J. Pathol."},{"issue":"7","key":"10.1016\/j.micpath.2020.104700_bib19","first-page":"1690","article-title":"Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils","volume":"12","author":"Thomsen","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2020.104700_bib20","doi-asserted-by":"crossref","first-page":"20724","DOI":"10.1038\/srep20724","article-title":"Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.micpath.2020.104700_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijmm.2015.10.005","article-title":"Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease","volume":"306","author":"Garg","year":"2016","journal-title":"NucAb. Int. J. Med. Microbiol."},{"issue":"7","key":"10.1016\/j.micpath.2020.104700_bib22","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1128\/IAI.02970-14","article-title":"Anti-Pseudomonas aeruginosa IgY antibodies induce specific bacterial aggregation and internalization in human polymorphonuclear neutrophils","volume":"83","author":"Thomsen","year":"2015","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.micpath.2020.104700_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jcf.2015.08.002","article-title":"Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model","volume":"15","author":"Thomsen","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.micpath.2020.104700_bib24","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3389\/fmicb.2016.01713","article-title":"Synergistic nisin-polymyxin combinations for the control of Pseudomonas biofilm formation","volume":"7","author":"Field","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2020.104700_bib25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: an emerging category of therapeutic agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front. Cellular Infect. Microbiol."},{"key":"10.1016\/j.micpath.2020.104700_bib26","doi-asserted-by":"crossref","first-page":"100900","DOI":"10.1016\/j.genrep.2020.100900","article-title":"Construction, cloning, and expression of Melittin antimicrobial peptide using Pichia pastoris expression system","volume":"21","author":"Moridi","year":"2020","journal-title":"Gene Rep."},{"key":"10.1016\/j.micpath.2020.104700_bib27","doi-asserted-by":"crossref","first-page":"100509","DOI":"10.1016\/j.genrep.2019.100509","article-title":"Preparation and evaluation of a new biopesticide solution candidate for plant disease control using pexiganan gene and Pichia pastoris expression system","volume":"17","author":"Neshani","year":"2019","journal-title":"Gene Rep."},{"key":"10.1016\/j.micpath.2020.104700_bib28","doi-asserted-by":"crossref","first-page":"100519","DOI":"10.1016\/j.genrep.2019.100519","article-title":"LL-37: review of antimicrobial profile against sensitive and antibiotic-resistant human bacterial pathogens","volume":"17","author":"Neshani","year":"2019","journal-title":"Gene Rep."},{"key":"10.1016\/j.micpath.2020.104700_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.peptides.2014.07.020","article-title":"Antibacterial peptide nisin: a potential role in the inhibition of oral pathogenic bacteria","volume":"60","author":"Tong","year":"2014","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.micpath.2020.104700_bib30","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nsmb830","article-title":"The nisin\u2013lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics","volume":"11","author":"Hsu","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"5","key":"10.1016\/j.micpath.2020.104700_bib31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ijantimicag.2019.03.009","article-title":"Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii","volume":"53","author":"Thomas","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"6","key":"10.1016\/j.micpath.2020.104700_bib32","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/AAC.02328-12","article-title":"Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells","volume":"57","author":"Naghmouchi","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.micpath.2020.104700_bib33","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1128\/AAC.02554-14","article-title":"LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents","volume":"58","author":"Haisma","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.micpath.2020.104700_bib34","first-page":"896","article-title":"Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa","volume":"101","author":"Zuravleff","year":"1983","journal-title":"J. Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.micpath.2020.104700_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3349\/ymj.2010.51.1.111","article-title":"In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains","volume":"51","author":"Dundar","year":"2010","journal-title":"Yonsei Med. J."},{"issue":"2","key":"10.1016\/j.micpath.2020.104700_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1469-0691.2006.01601.x","article-title":"Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome","volume":"13","author":"Kuo","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2020.104700_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/2059513119831369","article-title":"Molecular identification and genotyping of Acinetobacter baumannii isolated from burn patients by PCR and ERIC-PCR","volume":"5","author":"Falah","year":"2019","journal-title":"Scars, Burns Healing"},{"issue":"8","key":"10.1016\/j.micpath.2020.104700_bib38","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1007\/s00253-013-4709-0","article-title":"Improved PCR for identification of Pseudomonas aeruginosa","volume":"97","author":"Choi","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2020.104700_bib39","series-title":"Performance Standards for Antimicrobial Susceptibility Testing, Approved Standard M100-S30; 30th Informational Supplement","year":"2020"},{"issue":"4","key":"10.1016\/j.micpath.2020.104700_bib40","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/AEM.70.4.2398-2403.2004","article-title":"Evaluation of a scanner-assisted colorimetric MIC method for susceptibility testing of gram-negative fermentative bacteria","volume":"70","author":"Rahman","year":"2004","journal-title":"Appl. Environ. Microbiol."},{"issue":"9","key":"10.1016\/j.micpath.2020.104700_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1469-0691.2000.00149.x","article-title":"EUCAST Definitive Document E. Def 1.2, May 2000: terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents","volume":"6","author":"Eucast","year":"2000","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2020.104700_bib42","article-title":"Antibiotic resistance: what is so special about multidrug-resistant Gram-negative bacteria?","volume":"12","author":"Exner","year":"2017","journal-title":"GMS Hygiene Infect. Contr."},{"issue":"2","key":"10.1016\/j.micpath.2020.104700_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/mdr.2018.0016","article-title":"Highly synergistic effects of melittin with conventional antibiotics against multidrug-resistant isolates of acinetobacter baumannii and pseudomonas aeruginosa","volume":"25","author":"Akbari","year":"2019","journal-title":"Microb. Drug Resist."},{"issue":"4","key":"10.1016\/j.micpath.2020.104700_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/psc.2978","article-title":"Synergistic activity profile of an antimicrobial peptide against multidrug\u2010resistant and extensively drug\u2010resistant strains of Gram\u2010negative bacterial pathogens","volume":"23","author":"Pollini","year":"2017","journal-title":"J. Pept. Sci."},{"issue":"9","key":"10.1016\/j.micpath.2020.104700_bib45","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/molecules21091223","article-title":"Synergistic antipseudomonal effects of synthetic peptide AMP38 and carbapenems","volume":"21","author":"Rudilla","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2020.104700_bib46","first-page":"10","article-title":"Colistin exhibits diverse and strain dependant synergy IN combination with different antibiotics against acinetobacter baumannii strains","volume":"9","author":"Han","year":"2016","journal-title":"Choice"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020310664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020310664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:35:46Z","timestamp":1760110546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401020310664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":46,"alternative-id":["S0882401020310664"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104700","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104700"}}